Huberman Lab
Dr. Matthew Hill: How Cannabis Impacts Health & the Potential Risks
Dr. Matthew Hill
And this was like a treatment resistant population that was pretty severe. So this was a big benefit. So they then took open label and did what you should and moved forward to do a double-blind placebo-controlled. Now, it was a very small sampled studies. And that is obviously always a problem with human work is if this was like 15 or 17 people.
0
💬
0
Comments
Log in to comment.
There are no comments yet.